Responses
Epidemiology and outcomes
Original research
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE
Compose a Response to This Article
Other responses
No responses have been published for this article.